0.68% 0.25

Dopo l'orario di chiusura: 36.03 -0.74 -2.01%

Teva Pharmaceutical Industries Ltd Adr (TEVA)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché TEVA Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Teva Pharmaceutical Industries Ltd Adr (TEVA)

Teva Pharmaceutical Industries Ltd Adr Borsa (TEVA) Ultime notizie

Teva stock hits 52-week high at 37.35 USD By Investing.com - Investing.com Nigeria

Teva stock hits 52-week high at 37.35 USD - Investing.com

Moody’s upgrades Teva rating to investment grade on debt cuts By Investing.com - Investing.com UK

TEVA Stock Price, Quote & Chart - ChartMill

Teva Pharmaceutical Industries (TEVA) Lifts Outlook On Earnings As Valuation Debate Stays Open - Sahm

Teva (TEVA) Is Up 8.8% After Raising 2026 Guidance And Highlighting Innovative Drug Momentum - Sahm

July 2026's Top Stock Selections Estimated Below Intrinsic Value - Sahm

Teva Pharmaceutical Industries (TEVA) Raises Revenue Guidance, Is The 15% Undervaluation Still There? - Sahm

Teva Earnings: Innovation Engine Continues Firing and Supports Our Increased Moat Rating - Morningstar

Teva seeks clarity on Trump drug tariff plans, CEO says By Investing.com - Investing.com South Africa

Why Is Teva (NYSE:TEVA) Making NYSE Composite Headlines? - kalkinemedia.com

Daily Brief Health Care: Apnimed, Chugai Pharmaceutical, Equifax Inc, Royalty Pharma , Startline, Surgery Partners, Teva Pharmaceutical Sp Adr, Thermo Fisher Scientific Inc and more - Smartkarma

Teva Pharmaceutical Industries Limited Sponsored ADR Revenue Breakdown – BX:TEV - TradingView

Does Teva Pharmaceutical Industries (NYSE:TEVA) Still Look Undervalued After A 260% Run? - Sahm

Teva Pharmaceutical Industries Limited (TEVA) stock price, news, quote and history - Yahoo Finance UK

Teva Pharmaceutical Industries Limited (TEVA) Stock Price, News, Quote & History - Yahoo! Finance Canada

ETFs Investing in Teva Pharmaceutical Industries Limited Sponsored ADR Stocks - TradingView

What Teva Pharmaceutical Industries (TEVA)'s TEV‑408 Vitiligo Data and Funding Deal Means For Shareholders - Sahm

MINT,TEVA Volatility & Greeks - Finviz

Teva Pharmaceutical Industries (TEVA) Advances TEV 408, Is The Stock Still Cheap? - Sahm

Teva (TEVA) Stock Looks Reasonable Even With A 48% Gap - Sahm

Teva (TEVA) Advances TEV 408 Into Phase 2b For Vitiligo After Early Progress - Sahm

Novartis vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026? - The Motley Fool

Teva and Polpharma Biologics Announce Global Licensing Agreement for a Biosimilar Candidate to Ocrevus® (ocrelizumab) for Multiple Sclerosis - Sahm

Teva Reports Early Skin Repigmentation Data, Sets Stage For Next Trial - Sahm

Teva moves anti-IL-15 antibody to Phase 2b for vitiligo treatment - Investing.com

Teva stock leans on its generic drug base. - Ad-hoc-news.de

883035 Forecast — Price Target — Prediction for 2027 - TradingView

TEVATeva- Pharmaceutical Industries Ltd ADR Latest SEC Filings - Finviz

How Teva’s Ecopipam NDA for Pediatric Tourette Syndrome (TEVA) Has Changed Its Investment Story - Sahm

India Celiac Disease Treatment Market Size & Outlook, 2033 - Grand View Research

Enterprise value to revenue forward of Teva Pharmaceutical Industries Limited Sponsored ADR – BX:TEV - TradingView

Price to earnings forward of Teva Pharmaceutical Industries Limited Sponsored ADR – BX:TEV - TradingView

TEV Forecast — Price Target — Prediction for 2027 - TradingView

TEVA Forecast — Price Target — Prediction for 2027 - TradingView

TEVA/N Forecast — Price Target — Prediction for 2027 - TradingView

Enterprise value to revenue forward of Teva Pharmaceutical Industries Limited Sponsored ADR – FWB:TEV - TradingView

Price to earnings forward of Teva Pharmaceutical Industries Limited Sponsored ADR – FWB:TEV - TradingView

Enterprise value to EBITDA forward of Teva Pharmaceutical Industries Limited Sponsored ADR – FWB:TEV - TradingView

Teva Pharmaceutical Industries Ltd Unsponsored Brazilian Depositary Receipt Repr 0.5 ADR - TradingView

Teva Pharmaceutical Industries Limited Sponsored ADR - TradingView

TEVA News | TEVA PHARMACEUTICAL-SP ADR (NYSE:TEVA) - ChartMill

Teva's Shift Beyond Generics Puts Focus on Branded Drug Growth - TradingView

Why Is Teva Pharmaceutical (NYSE:TEVA) Drawing NYSE Composite Attention? - Kalkine Media

Teva Pharmaceutical Industries (TEVA) Stock Could Be 23.7% Undervalued After Recent Pullback - Sahm

Teva Seeks FDA Nod for Ecopipam in Pediatric Tourette Syndrome - Yahoo Finance

Teva submits new drug application for pediatric Tourette treatment By Investing.com - Investing.com Canada

FOCUS-US progesterone supplies tighten as menopause treatment demand grows - Sahm

Teva Extends Neuroscience Focus With Emalex Deal And Valuation Upside Potential - Sahm

Teva Closes Acquisition of Emalex Biosciences, Strengthening Late-Stage Neuroscience Pipeline and Advancing Pivot to Growth Strategy - Sahm

symbol__ Stock Quote Price and Forecast - CNN

ALVO Stock Gains 19% on FDA Resubmission of Biosimilar BLAs - TradingView

Simile a TEVA